Arkolith/Insider Trading/KTTA/Form 4

Camac Fund, LP

InsiderPasithea Therapeutics Corp. (KTTA) · full profile →Form 4 · filed Sep 30, 2022
Net Buying
Open-Market Buys
$76K
Open-Market Sells
$0
Net Open-Market Flow
$76K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 29, 2022Buy(P)7K$1.16$8K1.8M
Sep 28, 2022Buy(P)58K$1.19$69K1.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-051650) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML